ACKNOWLEDGEMENTS Cancer Research UK (CRUK) funded the National Cancer Research Institute (NCRI) PET Research Working party to organise a meeting to discuss imaging cancer with hypoxia tracers and Positron Emission Tomography. IF was funded by CRUK and is also supported by the Chief Scientific Office. ALH is supported by CRUK and the Breast Cancer Research Foundation. RM is funded by NIHR Cambridge Biomedical Research Centre. We would also like to thank Professors Tim Eisen and Duncan Jodrell, University of Cambridge, UK and Dr Anastasia Chalkidou, King’s College London, UK for providing the 18F-FMISO and 64CuATSM images illustrated in this reviewPeer reviewedPublisher PD
AbstractTumour hypoxia and its molecular responses have been shown to be associated with poor progno...
Objective: Oxygen-enhanced MRI (OE-MRI) or tissue oxygen-level dependent (TOLD) MRI is an imaging te...
Measurement of tumor hypoxia is required for the diagnosis of tumor and the evaluation of therapeuti...
Hypoxia, a hallmark of most solid tumours, is a negative prognostic factor due to its association wi...
A lack of oxygen caused by poorly formed blood vessels is a common phenomenon in tumours. These oxyg...
Tumour hypoxia represents a significant challenge to the curability of human tumours leading to trea...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Imaging (PET/CT scan) in cancer patients is an increasingly important element in both diagnosis and ...
Abstract: Hypoxia is a pathological condition arising in living tissues when oxygen supply does not ...
Tumour hypoxia is an important contributor to radioresistance. Thus, increasing the radiation dose t...
Purpose Hypoxia is a condition of insufficient oxygen to support metabolism which occurs when the va...
Tumour hypoxia is an important contributor to radioresistance. Thus, increasing the radiation dose t...
Funding: Funding for the pilot study was provided by the Colorectal Study Fund, a NHSG endowment fun...
Funder: National Institute for Health Research (NIHR) - Cambridge Biomedical Research CentreAbstract...
Tumour hypoxia represents a significant challenge to the curability of human tumours leading to trea...
AbstractTumour hypoxia and its molecular responses have been shown to be associated with poor progno...
Objective: Oxygen-enhanced MRI (OE-MRI) or tissue oxygen-level dependent (TOLD) MRI is an imaging te...
Measurement of tumor hypoxia is required for the diagnosis of tumor and the evaluation of therapeuti...
Hypoxia, a hallmark of most solid tumours, is a negative prognostic factor due to its association wi...
A lack of oxygen caused by poorly formed blood vessels is a common phenomenon in tumours. These oxyg...
Tumour hypoxia represents a significant challenge to the curability of human tumours leading to trea...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Imaging (PET/CT scan) in cancer patients is an increasingly important element in both diagnosis and ...
Abstract: Hypoxia is a pathological condition arising in living tissues when oxygen supply does not ...
Tumour hypoxia is an important contributor to radioresistance. Thus, increasing the radiation dose t...
Purpose Hypoxia is a condition of insufficient oxygen to support metabolism which occurs when the va...
Tumour hypoxia is an important contributor to radioresistance. Thus, increasing the radiation dose t...
Funding: Funding for the pilot study was provided by the Colorectal Study Fund, a NHSG endowment fun...
Funder: National Institute for Health Research (NIHR) - Cambridge Biomedical Research CentreAbstract...
Tumour hypoxia represents a significant challenge to the curability of human tumours leading to trea...
AbstractTumour hypoxia and its molecular responses have been shown to be associated with poor progno...
Objective: Oxygen-enhanced MRI (OE-MRI) or tissue oxygen-level dependent (TOLD) MRI is an imaging te...
Measurement of tumor hypoxia is required for the diagnosis of tumor and the evaluation of therapeuti...